According to Biolase 's latest financial reports the company's current EPS (TTM) is -HK$2,056. In 2022 the company made an earnings per share (EPS) of -HK$3,190 a decrease over its 2021 EPS that were of -HK$2,076.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$2,075 | -34.96% |
2022 | -HK$3,190 | 53.65% |
2021 | -HK$2,076 | -81.87% |
2020 | -HK$11,449 | -25.32% |
2019 | -HK$15,330 | -24.76% |
2018 | -HK$20,375 | -26.06% |
2017 | -HK$27,554 | 4.33% |
2016 | -HK$26,412 | -14.71% |
2015 | -HK$30,965 | -26.09% |
2014 | -HK$41,894 | 35.41% |
2013 | -HK$30,938 | 244.31% |
2012 | -HK$8,986 | -38.05% |
2011 | -HK$14,506 | -64.8% |
2010 | -HK$41,206 | 347.66% |
2009 | -HK$9,205 | -71.05% |
2008 | -HK$31,798 | 22.58% |
2007 | -HK$25,941 | 55% |
2006 | -HK$16,736 | -74.03% |
2005 | -HK$64,433 | -22.22% |
2004 | -HK$82,843 | -208.79% |
2003 | HK$76,148 | 1720% |
2002 | HK$4,184 | -171.43% |
2001 | -HK$5,858 | -65% |
2000 | -HK$16,736 | -28.57% |
1999 | -HK$23,430 | -56.92% |
1998 | -HK$54,392 | 209.52% |
1997 | -HK$17,573 | 5% |
1996 | -HK$16,736 |